SOPHROSYNE PHARMACEUTICALS
Live / Registered — Registered (as of 07 Oct 2025)
What this means for you
Registered since 07 Oct 2025. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98447760
- Registration number
- 7978019
- Mark type
- Stylized text
- Filed
- 13 Mar 2024
- Published for opposition
- 29 Oct 2024
- Registered
- 07 Oct 2025
- Attorney of record
- Aric S. Jacover
Goods and services
- Class 042 — Scientific and technological services: Research and development for FDA-approved prescription medications to address alcohol use disorder (AUD) and other addiction disorders, excluding nutritional supplements
Owner
- SOPHROSYNE PHARMACEUTICALS INC., CHICAGO, IL, US
- Sophrosyne Holdings LLC, Chicago, IL, US
- Sophrosyne Holdings LLC, Chicago, IL, US
- Sophrosyne Holdings LLC, Chicago, IL, US
Prosecution history
- 21 Jan 2026 — AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
- 07 Oct 2025 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 07 Oct 2025 — REGISTERED-PRINCIPAL REGISTER
- 03 Oct 2025 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 15 Sept 2025 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 15 Sept 2025 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 21 Aug 2025 — STATEMENT OF USE PROCESSING COMPLETE
- 30 Jul 2025 — USE AMENDMENT FILED
- 30 Jul 2025 — TEAS STATEMENT OF USE RECEIVED
- 22 Jul 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 22 Jul 2025 — SOU EXTENSION 1 GRANTED
- 09 Jun 2025 — SOU EXTENSION 1 FILED
- 21 Jul 2025 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 18 Jun 2025 — SOU EXTENSION RECEIVED WITH TEAS PETITION
- 18 Jun 2025 — NOTICE OF REVIVAL - E-MAILED